Japan To Resume HPV Vaccination To High School Students With GSK's Cervarix
This article was originally published in PharmAsia News
Executive Summary
After receiving supply confirmation from GlaxoSmithKline plc, maker of human papillomavirus vaccine Cervarix, Japan's Ministry of Health, Labor and Welfare will start HPV vaccinations June 10 to second-year high school girls who are receiving a first dose